AAS
BIAF icon

Ameritas Advisory Services’s bioAffinity Technologies BIAF Stock Holding History

Ameritas Advisory Services’s Portfolio BIAF Stock Details BIAF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-67
Closed -$3.83K – 1965
2026
Q1 		$3.83K Buy
+67
New +$1.62K ﹤0.01% 992

Other funds holding BIAF

SM
Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return
JSSH
J. Safra Sarasin Holding $6.97B AUM 32.91% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

Ameritas Advisory Services's BIAF Position: Q2 2026 in Review

Ameritas Advisory Services sold out of bioAffinity Technologies (BIAF) in Q2 2026, closing a stake of 67 shares — an estimated $3.83K sold.

Ameritas Advisory Services first reported a position in BIAF in Q1 2026 and held it in 1 quarter. The position peaked at $3.83K in Q1 2026. 19 funds tracked by Wall St. Rank hold BIAF as of Q2 2026.

  • Ameritas Advisory Services reported no remaining bioAffinity Technologies position as of Q2 2026 after selling out during the quarter.
  • Ameritas Advisory Services sold 67 bioAffinity Technologies shares in Q2 2026, an estimated $3.83K.
  • Ameritas Advisory Services first reported a position in bioAffinity Technologies in Q1 2026 and held it in 1 quarter.
  • Ameritas Advisory Services's bioAffinity Technologies position peaked at $3.83K in Q1 2026.
  • 19 funds tracked by Wall St. Rank held bioAffinity Technologies as of Q2 2026.

Based on Ameritas Advisory Services's 13F filing for Q2 2026, filed 14 Aug 2026.